Home
About Us
Our Mission
Management
Board of Directors
Science Advisors
Science & Pipeline
Overview
Neuroplasticity
DMX-1001
Alcohol use disorder
Publications
Investors & Media
Media releases
News beats
For Investors
Media contact
Contact DemeRx
Ibogaine: Past Advances and Future Perspectives – Oct 23
changes
Upcoming Events
24 Oct at 11:04 am
Next Post
DemeRx Awarded $1.7 Million National Institutes of Health Grant
Previous Post
DemeRx Welcomes E. Matthew “Whiz” Buckley to Advisory Board
Menu
